Live Breaking News & Updates on Biochemical Industries

Stay updated with breaking news from Biochemical industries. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Study in JNCCN Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer Patients

According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with critical information they need to guide therapy for pancreatic cancer patients. Increasingly impactful nature of research in JNCCN reflected in new high for the journal's Impact Factor, now 12.693. PLYMOUTH MEETING, Pa., Sept. 9, 2022 /PRNewswire/ New research in the September 2022 issue of JNCCN-Journal of the National Comprehensive Cancer Networkfinds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic benefit in objectively assessing neoadjuvant chemotherapy response in borderline resectable/locally advanced pancreatic cancer patients prior to surgery. "We were astonished by how metabolic imaging can now predict outcomes with high accuracy before any surgical intervention," said senior research Mark J. Truty, MD, MS, ....

United States , Mahmoudm Al Hawary , Amrom Abdelrahman , Ajith Goenka , Facebook Nccnorg , Instagram Nccnorg , Panel For Pancreatic Adenocarcinoma , University Of Michigan Rogel Cancer Center , National Comprehensive Cancer Network , Mayo Clinic Comprehensive Cancer Center , Impact Factor , Mayo Clinic Comprehensive Cancer , Michigan Rogel Cancer Center , Pancreatic Adenocarcinoma , Neoadjuvant Therapy Response , Locally Advanced Pancreatic , National Comprehensive Cancer , Practice Guidelines , According To Mayo Clinic Comprehensive Cancer Center Researchers , Etabolic Imaging Fdg Pet In Combination With Traditional Treatment Response Assessment Methods Can Provide Clinicians Critical Information They Need To Guide Therapy For Pancreatic Cancer Patients Increasingly Impactful Nature Of Research Jnccn Reflected New High The Journal 39s Impact Factor , Ow 12 693 Plymouth Meeting , Sept 9 , 022 Prnewswire New Research In The September 2022 Issue Of Jnccn Journal National Comprehensive Cancer Networkfinds Use Positron Emission Tomography Pet With 18 Fluorodeoxyglucose Fdg Tracer Adds Significant Prognostic Benefit Objectively Assessing Neoadjuvant Chemotherapy Response Borderline Resectable Locally Advanced Pancreatic Patients Prior To Surgery Quot We Were Astonished By How Metabolic Imaging Can Now Predict Outcomes High Accuracy Before Any Surgical Intervention , Uot Said Senior Research Markj Truty , Ayo Clinic Comprehensive Cancer Center Quot Not Only That , Ut Fdg Pet Response Was The Single Largest Preoperative Predictor Of Survival For These Patients Decisively Identified More Than 85 Suspected To Have Major Pathological Responses This Isa Very Impressive Proportion And Better Currently Available Biochemical Assessment Through Ca 19 9 Levels Alone ,

IIT Mandi researchers discover a biochemical link between fatty liver disease and Type 2 Diabetes

Uniindia: Mandi (HP), Sep 6 (UNI) Researchers at the Indian Institute of Technology Mandi have unraveled the biochemical relationship between fatty liver disease and Type 2 Diabetes Mellitus (T2DM). This understanding enables newer techniques to diagnose the risk of Diabetes among people with Non-Alcoholic Fatty Liver Disease (NAFLD). ....

West Bengal , Souveek Mitra , Prosenjit Mondal , P Vineeth Daniel , Surbhi Dogra , Avishek Paul , Kausik Das , Debajyoti Das , Priya Rawat , Partha Chakrabarti , School Of Biosciences , Indian Institute Of Technology Mandi , Csir Indian Institute Of Chemical Biology , Indian Institute , Technology Mandi , Non Alcoholic Fatty Liver Disease , Journal Diabetes , Associate Professor , Chemical Biology , Advanced Glycation End ,

Blue Earth Diagnostics Announces Reader Reproducibility Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

- Oral presentation highlighted at 2022 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting - Blue Earth Diagnostics, a Bracco company and recognized leader in the development ....

United States , United Kingdom , Phillip Kuo , Scintomics Gmb , Kostenloser Wertpapierhandel , Davide Gauden , Clare Gidley , Mike Beyer , Priscilla Harlan , Study Group , Drug Administration , Sam Brown Inc , Bracco Group , Technical University Of Munich , Nuclear Medicine , Corporate Communications , Society Of Nuclear Medicine , University Of Arizona , Molecular Imaging , Annual Meeting , Earth Diagnostics , Prostate Specific Membrane Antigen Targeted , Business Wire , Medical Imaging , Biomedical Engineering , New Drug Application ,

STK Bio-Ag Technologies: STK's REGEV Hybrid Fungicide Wins Best Biochemical Product of the Year

STK Bio-Ag Technologies, a pioneer in the development and marketing of botanical based and hybrid solutions for crop protection, received the Best Biochemical Product of the Year Award from the World ....

United States , United Kingdom , Kostenloser Wertpapierhandel , Merav Fishelson , Mark Whittaker , Shay Shaanan , Arye Tenenbaum , Bioprotection Forum , Tea Tree Oil , World Bioprotection Forum , Sales Development , Business Development , Business Development Shay Shaanan , Best Biochemical Product , Year Award , Business Development Shay , Business Wire , Biochemical Product , World Bioprotection , Latin America , East Asia ,

Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

- Oral presentation based on Late-breaking Abstract featured at American Urological Association's 2022 Annual Meeting (AUA2022) - Blue Earth Diagnostics, a Bracco company and recognized leader in ....

United States , United Kingdom , Scintomics Gmb , Kostenloser Wertpapierhandel , Georgina Mowatt , Markt Fleming , Davide Gauden , Mike Beyer , Priscilla Harlan , Study Group , Drug Administration , American Urological Association , Sam Brown Inc , Bracco Group , Technical University Of Munich , Virginia Oncology Associates , Us Oncology Research , Nuclear Medicine , Corporate Communications , Late Breaking Abstract , Earth Diagnostics , Prostate Specific Membrane Antigen Targeted , True Positive , New Drug Application , Chief Executive Officer , Blue Earth ,